Docosahexaenoic Acid (DHA) Reduces Inflammation and Aromatase Expression in Subcutaneous Fat and Inflammation in the Rectosigmoid Mucosa in Obese Postmenopausal Women: A Pilot Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Obesity
- Focus Pharmacodynamics
Most Recent Events
- 13 Mar 2017 Biomarkers information updated
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.